Assignment of Assignor's Interest

Recorded: 2014-06-09 Pages: 5

Assignor

THERAVANCE, INC.

Executed: 2014-06-01

Assignee

THERAVANCE BIOPHARMA R&D IP, LLC

901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080

Covered Properties (4)

Aryl Aniline BETA2 Adrenergic Receptor Agonists

Patent: 6,653,323 →

Application: 10/292,211 →

Publication: US 2003/0153597

Aryl Aniline BETA2 Adrenergic Receptor Agonists

Patent: 6,949,568 →

Application: 10/642,926 →

Publication: US 2004/0059116

Aryl Aniline BETA2 Adrenergic Receptor Agonists

Patent: 7,452,995 →

Application: 11/102,197 →

Publication: US 2005/0192316

Novel aryl aniline beta-2 adrenergic receptor agonists

Application: 60/338,194 →

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.